GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
GlaxoSmithKline, on Wednesday, announced that the companies have entered into an agreement under which GSK will acquire a California- based Sierra Oncology, a biopharmaceutical company…
Read More...
Read More...